Your browser doesn't support javascript.
loading
Diminished Neutralization Capacity of SARS-CoV-2 Omicron BA.1 in Donor Plasma Collected from January to March 2021.
Lin, Yi-Chan J; Evans, David H; Robbins, Ninette F; Orjuela, Guillermo; Abe, Kento T; Rathod, Bhavisha; Colwill, Karen; Gingras, Anne-Claude; Tuite, Ashleigh; Yi, Qi-Long; O'Brien, Sheila F; Drews, Steven J.
Afiliação
  • Lin YJ; Department of Medical Microbiology & Immunology, University of Alberta, Edmonton, Canada.
  • Evans DH; Department of Medical Microbiology & Immunology, University of Alberta, Edmonton, Canada.
  • Robbins NF; Scientific Affairs, Abbott Transfusion Medicine, Chicago, Illinois, USA.
  • Orjuela G; Scientific Affairs, Abbott Transfusion Medicine, Bogotá, Colombia.
  • Abe KT; Lunenfeld-Tanenbaum Research Institute at Mt. Sinai Hospital, Sinai Health, Toronto, Ontario, Canada.
  • Rathod B; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
  • Colwill K; Lunenfeld-Tanenbaum Research Institute at Mt. Sinai Hospital, Sinai Health, Toronto, Ontario, Canada.
  • Gingras AC; Lunenfeld-Tanenbaum Research Institute at Mt. Sinai Hospital, Sinai Health, Toronto, Ontario, Canada.
  • Tuite A; Lunenfeld-Tanenbaum Research Institute at Mt. Sinai Hospital, Sinai Health, Toronto, Ontario, Canada.
  • Yi QL; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
  • O'Brien SF; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
  • Drews SJ; Epidemiology and Surveillance, Canadian Blood Services, Ottawa, Ontario, Canada.
Microbiol Spectr ; 11(4): e0525622, 2023 08 17.
Article em En | MEDLINE | ID: mdl-37289096

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Humans País como assunto: America do norte Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Humans País como assunto: America do norte Idioma: En Ano de publicação: 2023 Tipo de documento: Article